本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ikena Oncology, Inc.

1.32
-0.0200-1.49%
盘前1.370.0500+3.79%08:00 EDT
成交量:3.06万
成交额:4.07万
市值:6,370.07万
市盈率:-1.53
高:1.35
开:1.35
低:1.32
收:1.34
数据加载中...
2025/07/01

重要事件披露

Form 8-K - Current report
2025/07/01

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/06

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/12/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/12/23

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/12

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]